Life Sciences MVP: Sullivan & Cromwell's Frank Aquila

Law360, Los Angeles (December 11, 2013, 7:41 PM EST) -- This past year, Sullivan & Cromwell LLP's Frank Aquila guided Amgen Inc. in its $10.4 billion acquisition of Onyx Pharmaceuticals Inc., strengthening the biotechnology firm's cancer drug portfolio and earning him a spot among Law360's Life Sciences MVPs of 2013.

Aquila, co-head of Sullivan & Cromwell's general practice group, led a team of attorneys who advised Thousand Oaks, Calif.-based Amgen on its acquisition of Onyx, which closed in October. The deal — Amgen's second-largest ever — was representative of a broader trend throughout the industry, he...
To view the full article, register now.